Filing Details
- Accession Number:
- 0001214659-21-001555
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-11 16:39:43
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2021-02-11 16:39:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581280 | Twist Bioscience Corp | TWST | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283576 | Nicolas Barthelemy | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-09 | 5,000 | $23.33 | 6,898 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-09 | 5,000 | $177.61 | 1,898 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (right to buy) | Disposition | 2021-02-09 | 5,000 | $0.00 | 5,000 | $23.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,573 | 2029-10-23 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price per share. The shares sold at prices ranging from $177.22 to $178.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- 1/3rd of the shares subject to the option vested and became exercisable on October 24, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.